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It is now twenty years since Wertheimer and Leeper (1979)
published the first study suggesting an association between resi-
dential exposure to extremely low frequency magnetic fields
(EMF) and childhood cancer. Ever since, this has been a contro-
versial issue with the findings from several, but not all, subse-
quent epidemiological studies being consistent with an
association, particularly with respect to residential exposure and
childhood leukaemia (Portier and Wolfe, 1998). However, many
of the reports have been based on small numbers of exposed
cases, and despite intense experimental research no known
biophysical mechanism to explain an effect has been estab-
lished.
We conducted a pooled analysis based on primary data from
nine studies on EMF and childhood leukaemia, addressing three
specific questions:
1. Do the combined results of these studies indicate that there is
an association between EMF exposure and childhood
leukaemia risk, which is larger than one would expect from
random variability?
2. Does adjustment for confounding from socioeconomic class,
mobility, level of urbanization, detached/not detached
dwelling, and level of traffic exhaust change the results?
3. Do the combined data support the existence of the so-called
wire code paradox, that is, a stronger association between
proxy measures of EMF and cancer than between direct
measurements and cancer?
METHODS
The original plan for this project was to include all European
studies that addressed the question of an association between EMF
and childhood leukaemia and were based on either 24 or 48 hour
magnetic field measurements or calculated fields. At the time five
such studies were reported (Feychting and Ahlbom, 1993; Olsen 
et al, 1993; Verkasalo et al, 1993; Tynes and Haldorsen, 1997;
Michaelis et al, 1998). In addition, a nationwide childhood cancer
study was in progress and near completion in the UK (UKCCS,
1999). Since we were not aware of any other European study to be
published in the near future, the inclusion of the UK study would
give us a complete set of European studies. We felt that if we could
also incorporate new studies from non-European countries this
pooled analysis would be up to date and presumably stay current
for several years. We were aware of three more studies in other
parts of the world with compatible information that were all nearly
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(Linet et al, 1997; Dockerty et al, 1998, 1999; McBride et al,
1999). Table 1 lists the studies and their relevant characteristics. A
fourth study was also near completion in Ontario, Canada, but it
was decided that since this study did not provide 24-hour indoor
measurements, or anything similar to it, the exposure information
in this study was not similar enough to justify inclusion (Green et
al, 1999a,b). In effect, all large-scale published studies with
extended indoor measurements or calculated fields were included
in the pooled analysis with the exception of a few studies that were
not population based.
The primary analyses reported here were all discussed and
agreed upon prior to the commencement of the work. This
included diagnostic categories, exposure definitions, time period
for evaluation, cut points, confounders, and statistical methods. In
addition certain analyses were done to confirm that the findings
from these primary analyses were not dependent on these specifi-
cations and yet other analyses were done with an exploratory
purpose.
This pooled analysis focused on childhood leukaemia, even
though several of the studies also included other cancer diagnoses.
The US study included only acute lymphocytic leukaemia (ALL).
We did analyses both for total leukaemia and for ALL, but for
brevity the more detailed results are given for total leukaemia.
There was some variation with respect to age groups in the studies,
and we decided to use the age interval 0–14 years.
Since we wanted the data to be as consistent as possible 
across studies, the data that we used from a particular study were
sometimes different from those that formed the basis for the orig-
inal publication from that study. This was particularly the case
with the exposure variables (Table 1). In effect, the study-specific
results that we report in this article differ to various degrees from
the results as reported in the original publications. These differ-
ences are biggest for the US study. Compared with the published
results of the US study, the pooled analysis included fewer cases
and controls (34 cases and 90 controls were excluded because
24/48-hour measurements were missing), limited the study period
to the year prior to diagnosis rather than the five years immediately
prior to diagnosis, restricted the number of residences for which
measurements were utilized to one per subject rather than all
homes resided in during the five years immediately prior to diag-
nosis, and used geometric means rather than arithmetic means.
In studies with long magnetic field measurements (24/48-hour),
these were chosen as the primary exposure measure. The publica-
tion from the Canadian study uses personal measurements, but to
achieve consistency with the other studies we chose to use the in-
home measurements instead. In the UK, a two-phase measurement
strategy was used, according to which 48-hour measurements were
conducted when either a shorter measurement (108 minutes) or a
characteristic of the residency indicated that EMF exposure was
elevated. These measurements were all treated as long measure-
ments because almost all elevated readings would come from 48-
hour measurements. None of the adjustments to the measured
exposure that were presented in the UKCCS analysis were used in
the pooled analysis. (It should be noted that these adjustments had
negligible effect.)
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Table 1 Relevant characteristics for studies included in the pooled analysis
Subjects Exposure Matching Potential confounders
measures variables Common Study specific (no. of groups)
Measure of
social status
Canada 272 304 1990–94          32
Denmark 833 4746 1968–86        54
Finlanda 29 1027 1974–93      2
Germany 175 409 1992–95         23 2 2 c
New Zealand 86 80 1990–93       52
Norway 148 572 1965–89         62
Sweden 36 508 1960–85         42 3
USAb 595 530 1989–94          64
UK 1073 2224 1992–96       7
Specification of exposure information selected for the pooled analysis
Canada Latest home inhabited before diagnosis for which a 24-hour bedroom measurement was available (may not be same
home for long measurement & wire code)
Denmark Latest home inhabited before diagnosis for which a calculated field was available
Finland Calculated field for 12 months prior to diagnosis was provided especially for this exercise (may be average of values
for more than one home)
Germany Latest home inhabited before diagnosis (was home at diagnosis for almost all individuals)
New Zealand Home inhabited at diagnosis
Norway Latest home inhabited before diagnosis in which child lived in the power line corridor, field calculated for entire period
Sweden Latest home inhabited before diagnosis in which child lived in the power line corridor, field calculated for entire period
USA Latest home inhabited before diagnosis for which a record was available (may not be same home for long
measurement & wire code)
UK Home inhabited at diagnosis (UKCCS selection meant that the child must have lived there for previous 12 months)
aCase control data generated from the original cohort; bacute lymphoblastic leukaemia only; cEast/West Germany.
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sAs a summation of all measurements for one subject, over the
24/48 hours, most of the centres used arithmetic means. We
decided, however, to use geometric means from all studies,
because they are less affected by outliers. For comparison we also
analysed the data using arithmetic means. Therefore, each centre
provided the geometric means as well as the arithmetic means,
regardless of what they used in their original publication.
All centres without long measurements had calculated fields,
i.e., calculations of magnetic fields based upon distance between
the subject’s home and the nearby power line, line characteristics,
and load on the line. For these centres calculated fields were
evaluated as the primary measure.
We also analysed wire-codes (i.e., a proxy measure of residen-
tial magnetic field level, based on the distance and configuration 
of nearby power lines) for all North American studies. These 
were classified and analysed according to the original
Wertheimer–Leeper scheme (Wertheimer and Leeper, 1982). We
also developed a European version of the wire-code, but eventu-
ally decided that the differences between the North American and
the European distribution systems were too large to make this
meaningful. The wire-code analyses, therefore, only included the
North American studies.
With respect to the reference time for exposure characterization,
there was considerable variation across studies. Residential
measurement data were available for various periods from birth to
diagnosis. We decided to aim for the average exposure during the
last year prior to diagnosis for the cases and the corresponding age
for the controls. We achieved this by using the exposure informa-
tion for the home at the time of diagnosis for the cases and the
home lived in by the matched control at the same age; when this
information was unavailable we used instead the latest time period
prior to diagnosis (Table 1). The reasons were that all studies could
provide exposure data specified in this way and that exposure
close to date of diagnosis is relevant to the hypothesis that EMF, if
anything, would act as a promoter.
All studies utilized a matched case-control design, although the
matching variables were not the same in all studies (Table 1). In
Finland the original publication reported findings from a cohort
study, but in preparation for this pooled analysis a control group
was selected and the data were evaluated using a matched case-
control design with 3 additional years of follow-up. Because we
wanted to use as many as possible of the cases and controls to
increase the flexibility of the analysis, we decided to ignore the
matching. Instead we included adjustment for age and sex in all
analyses, with age classified into one-year groups up to five years
of age and then into five year groups. In all analyses, the measure-
ment studies were also adjusted for socio-economic status,
according to centre-specific definitions (Table 1). In addition, we
adjusted for residence in the eastern or western part of the country
in Germany.
One of the aims of this study was to test whether adjustment for
any available covariate would have an effect on the summary rela-
tive risk estimates. In addition to the covariates included in the
basic model, the following factors were available: socioeconomic
status, mobility, level of urbanization, detached/not detached
dwelling, and level of traffic exhaust. All of these variables were
not available in all studies (Table 1). For socioeconomic class,
level of urbanization, residential mobility, and traffic exhaust, the
basic information and the definitions varied between centres as
described in Table 1.
To estimate a summary relative risk across centres, a logistic
regression model was applied to the raw data, with centres repre-
sented by dummy variables. We did this for measurement studies
and calculated field studies separately but also across all studies.
In the primary analyses, exposure was categorized in the four
levels: < 0.1 µ T; 0.1–<0.2 µ T; 0.2–<0.4 µ T; ≥ 0.4 µ T and entered
into the model with the use of dummy variables. The wire-code
analyses were treated correspondingly. In addition, a similar
analysis but with continuous exposure was conducted, the results
of which are reported as relative risks per 0.2 µ T intervals. This
continuous analysis was also the basis for a likelihood ratio test of
homogeneity of effects across studies.
RESULTS
Table 2 gives the absolute numbers of subjects by case/control
status, study, and exposure level. In total there are 3247 cases and
10 400 controls. The UK provided by far the largest number of
cases, while Denmark had the largest number of controls. In the
highest exposure category (≥ 0.4 µ T) there were 44 cases and 62
controls, with the largest number of cases from the USA and the
largest number of controls from Sweden. Out of the 3247 cases,
2704 (83%) are ALL cases. The US study was restricted to ALL,
which explains why the US numbers are the same in the left and
right panels of Table 2.
In Table 3 we summarize the primary results for total leukaemia.
For each centre the relative risks are estimated by exposure level
and with adjustment for the basic potential confounders. Some of
the studies are based on small numbers, particularly the highest
exposure categories, and in some instances there are zero cases or
controls. Although some of the centre-specific relative risk esti-
mates are of little interest in themselves, particularly in the higher
categories, all studies still provide information for the summary
measures. The last column of the table gives the results of the
logistic regression analysis with continuous exposure. The homo-
geneity test based on the continuous analysis across all nine centres
resulted in a χ 2 with eight degrees of freedom of 10.7 corre-
sponding to a P value of 0.22. The interpretation is that the varia-
tion in point estimates between the studies, is not larger than one
would expect from random variability. We compared results for
matched versus unmatched analyses to confirm that ignoring the
matching did not introduce a bias. Because the results were similar,
we only report the unmatched results.
Across the measurement studies, the summary relative risk is
estimated at 1.87 (95% CI.: 1.10–3.18) in the highest exposure
category, with a corresponding P value of 0.01. The two lower
categories have estimates close to unity. For the calculated fields
studies the summary measure for the top exposure category is 2.13
(0.93–4.88), with a P value of 0.04.
In the very last line of Table 3, we give the summary relative
risk estimate across all studies, regardless of whether the study is a
measurement study or a calculated field study. We consider this an
analysis based on the exposure measure that is closest to the spec-
ified magnetic field measurement and time period of study defined
for the pooled analysis. The relative risk estimates in the two inter-
mediate exposure categories are near the no effect value, while in
the top category (≥ 0.4 µ T) the relative risk estimate is 2.00 (95%
CIs: 1.27–3.13), with a P value of 0.002. The continuous analysis
gives a relative risk estimate per 0.2 µ T of 1.15 (1.04–1.27) with a
test for trend P value of 0.004.
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estimates were higher when geometric rather than arithmetic
means were employed the data were reanalysed using arithmetic
means. Although the summary relative risk for all measurement
studies was still elevated 1.59 (1.04–2.45), it was lower than that
obtained when the analysis was based on geometric means.
While the primary categorical analyses were based on the prede-
termined cut off points, we evaluated the robustness of the results
by also using other cut off points. With 0.3–<0.4, 0.4–<0.5 and ≥
0.5 µ T as the three highest categories we found, across all studies
and for total leukaemia, relative risks of 1.60, 2.54 and 1.75,
respectively.
The largest studies and therefore the studies that carry most of the
weight in the summations are those from the US, Canada, and the
UK. If the US study were to be excluded, the summary estimate for
the highest exposure category would be reduced from 2.00 to 1.68
(1.00–2.83; P = 0.03). The exclusion of Canada would increase the
summary estimates to 2.14 (1.27–3.61), while exclusion of the UK
study would increase it to 2.29 (1.41–3.74). Table 3 also gives the
expected number of cases in the highest category under the null
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Table 2 Absolute numbers of childhood leukaemia cases and controls by study and exposure level
Measurement studies
Leukaemia cases < 0.1 0.1–0.2 0.2–0.4 ≥ 0.4 Total ALL cases < 0.1 0.1–0.2 0.2–0.4 ≥ 0.4 Total
Canada 174 56 29 13 272 151 50 26 12 239
Germany 156 12 5 2 175 130 10 5 2 147
New Zealand 76 6 4 0 86 64 5 3 0 72
UK 1018 38 13 4 1073 859 34 10 3 906
USA 418 111 49 17 595 418 111 49 17 595
Total 1842 223 100 36 2201 1622 210 93 34 1959
Controls < 0.1 0.1–0.2 0.2–0.4 ≥ 0.4 Total
Canada 215 53 26 10 304
Germany 380 21 6 2 409
New Zealand 72 8 0 0 80
UK 2099 91 26 8 2224
USA 386 95 44 5 530
Total 3152 268 102 25 3547
Calculated fields studies
Leukaemia cases < 0.1 0.1–0.2 0.2–0.4 ≥ 0.4 Total ALL cases < 0.1 0.1–0.2 0.2–0.4 ≥ 0.4 Total
Denmark 830 1 0 2 833 596 0 0 2 598
Finland 27 0 1 1 29 25 0 1 1 27
Norway 140 6 2 0 148 92 5 2 0 99
Sweden 27 3 1 5 36 17 1 0 3 21
Total 1024 10 4 8 1046 730 6 3 6 745
Controls < 0.1 0.1–0.2 0.2–0.4 ≥ 0.4 Total
Denmark 4736 2 8 0 4746
Finland 991 19 10 7 1027
Norway 542 13 7 10 572
Sweden 438 30 20 20 508
Total 6707 64 45 37 6853
Table 3 Total leukaemia. Relative risks (95% CI) by exposure level and with exposure as continuous variable (RR per 0.2 µ T) with adjustment for age, sex,
and SES (measurement studies) and East/West in Germany. Reference level: < 0.1 µ T. Observed (O) and expected (E) case numbers ≥ 0.4 µ T, with expected
nos. given by modelling probability of membership of each exposure category based on distribution of controls including covariates.
Type of study 0.1–< 0.2 µ T 0.2–<0.4 µ T ≥ 0.4 µ T O E Continuous
analysis
Measurement studies
Canada 1.29 (0.84–1.99) 1.39 (0.78–2.48) 1.55 (0.65–3.68) 13 10.3 1.21 (0.96–1.52)
Germany 1.24 (0.58–2.64) 1.67 (0.48–5.83) 2.00 (0.26–15.17) 2 0.9 1.31 (0.76–2.26)
New Zealand 0.67 (0.20–2.20) 4 cases/0 ctrls 0 cases/0 ctrls 0 0 1.36 (0.40–4.61)
UK 0.84 (0.57–1.24) 0.98 (0.50–1.93) 1.00 (0.30–3.37) 4 4.4 0.93 (0.69–1.25)
USA 1.11 (0.81–1.53) 1.01 (0.65–1.57) 3.44 (1.24–9.54) 17 4.7 1.30 (1.01–1.67)
Calculated fields studies
Denmark 2.68 (0.24–30.45) 0 cases/8 ctrls 2 cases/0 ctrls 2 0 1.50 (0.85–2.65)
Finland 0 cases/19 ctrls 4.11 (0.48–35.1) 6.21 (0.68–56.9) 1 0.2 1.15 (0.79–1.66)
Norway 1.75 (0.65–4.72) 1.06 (0.21–5.22) 0 cases/10 ctrls 0 2.7 0.78 (0.50–1.23)
Sweden 1.75 (0.48–6.37) 0.57 (0.07–4.65) 3.74 (1.23–11.37) 5 1.5 1.31 (0.98–1.73)
Summary
Measurement studies 1.05 (0.86–1.28) 1.15 (0.85–1.54) 1.87 (1.10–3.18) 36 20.1 1.17 (1.02–1.34)
Calculated fields studies 1.58 (0.77–3.25) 0.79 (0.27–2.28) 2.13 (0.93–4.88) 8 4.4 1.11 (0.94–1.30)
All studies 1.08 (0.89–1.31) 1.11 (0.84–1.47) 2.00 (1.27–3.13) 44 24.2 1.15 (1.04–1.27)hypothesis. The total number of excess cases across all studies is 20,
the largest number being contributed by the US study.
We then restricted these analyses to ALL. Since the ALL cases
make up as much as 83% of all cases and since the controls are the
same, the ALL results must be similar to the total leukaemia
results. The results in Table 4 show that this is indeed the case, but
in the highest exposure category the ALL relative risks are some-
what higher than for total leukaemia.
We also looked separately at other leukaemia to see whether the
observed excess risk was restricted to the ALL group. The
summary relative risk for other leukaemia was 1.42 in the highest
exposure category, but based on only 4 exposed cases.
Next we addressed the issue of a possible effect of adjustment
for more covariates. The results of this analysis are given in Table
5. In addition to the centres using different definitions of potential
confounders we also faced the problem that all centres did not
have data on all potential confounders. When we adjusted for a
particular confounder we therefore included only those studies that
have data on that confounder. Because of the centre specific differ-
ences in relative risks we could not compare the adjusted results
calculated from only a subset of the studies to the basic model
results calculated from all the studies. Therefore, in Table 5 we
present results with and without adjustment for a potential
confounder for the group of studies that the estimates are based
upon. As can be seen in Table 5, for none of the potential
confounders does the adjustment result in anything but minor
changes in any of the relative risk estimates.
The final issue is the so-called wire-code paradox. Table 6 has
the results according to wire-code categories including a summary
estimate for the two North American studies. In the table we also
give magnetic field levels for each wire code category. The rela-
tive risk for the highest wire-code category is 1.24 (0.82–1.87) so
these analyses do not provide evidence for the existence of such a
paradox.
DISCUSSION
We did not find any evidence of an increased risk of childhood
leukaemia at residential magnetic field levels < 0.4 µ T. We did,
however, find a statistically significant relative risk estimate of
two for childhood leukaemia in children with residential exposure
to EMF ≥ 0.4 µ T during the year prior to diagnosis. Less than 1%
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Table 4 Acute lymphocytic leukaemia. Relative risks (95% CI) by exposure level with adjustment for age, sex, and
SES (measurement studies) and East/West in Germany. Reference level: < 0.1 µ T.
Measurement studies 0.1–<0.2 µ T 0.2–<0.4 µ T ≥ 0.4 µ T
Canada 1.33 (0.85–2.07) 1.44 (0.79–2.60) 1.65 (0.68–4.01)
Germany 1.29 (0.58–2.89) 2.19 (0.62–7.71) 2.21 (0.29–16.7)
New Zealand 0.71 (0.21–2.44) 3 cases/0 ctrls 0 cases/0 ctrls
UK 0.89 (0.59–1.34) 0.87 (0.42–1.84) 0.88 (0.23–3.39)
USA 1.11 (0.81–1.53) 1.01 (0.65–1.57) 3.44 (1.24–9.54)
Calculated fields studies
Denmark 0 cases/2 ctrls 0 cases/8 ctrls 2 cases/0 ctrls
Finland 0 cases/19 ctrls 4.31 (0.50–37.2) 6.79 (0.74–62.6)
Norway 2.25 (0.78–6.55) 1.49 (0.30–7.45) 0 cases/10 ctrls
Sweden 0.88 (0.11–7.19) 0 cases/20 ctrls 3.46 (0.84–14.3)
Summary
Measurement studies 1.07 (0.87–1.31) 1.15 (0.84–1.56) 1.95 (1.14–3.35)
Calculated fields studies 1.42 (0.58–3.45) 0.84 (0.25–2.81) 2.23 (0.88–5.65)
All studies 1.08 (0.88–1.32) 1.12 (0.84–1.51) 2.08 (1.30–3.33)
Table 5 Summary relative risks. (95% CI) for total leukaemia by exposure level based on best available measure with adjustment for
potential confounders. Germany also includes East/West adjustment.
0.1–<0.2 µ T 0.2–<0.4 µ T ≥ 0.4 µ T
All studies but Finland
Age, sex 1.07 (0.88–1.29) 1.11 (0.84–1.47) 1.91 (1.21–2.99)
Age, sex, SES 1.08 (0.89–1.31) 1.10 (0.82–1.46) 1.92 (1.22–3.02)
All studies but UK
Age, sex, SES 1.18 (0.94–1.48) 1.15 (0.84–1.58) 2.28 (1.40–3.71)
Age, sex, SES, Urban 1.13 (0.90–1.42) 1.09 (0.79–1.50) 2.24 (1.37–3.67)
All studies but UK, Denmark, Finland, and NZ
Age, sex, SES 1.20 (0.96–1.52) 1.15 (0.83–1.58) 1.97 (1.19–3.25)
Age, sex, SES, type of dwelling 1.21 (0.96–1.52) 1.15 (0.83–1.59) 1.97 (1.19–3.26)
All studies but UK and Finland
Age, sex, SES 1.19 (0.95–1.49) 1.13 (0.83–1.55) 2.20 (1.34–3.61)
Age, sex, SES, mobility 1.18 (0.94–1.48) 1.14 (0.83–1.56) 2.20 (1.34–3.61)
Sweden and Germany
Age, sex, SES 1.37 (0.71–2.64) 1.28 (0.47–3.51) 3.30 (1.24–8.81)
Age, sex, SES, car exhaust 1.36 (0.70–2.63) 1.27 (0.46–3.49) 3.24 (1.22–8.63)
Reference level: < 0.1 µ T.of subjects were in this highest exposure category. The results did
not change following adjustment for the potential confounders. In
addition, the existence of the so-called wire-code paradox could
not be confirmed.
Earlier analyses of the hypothesis of an association between
EMF and cancer have sometimes been criticized on the grounds
that the findings might be a consequence of so-called data
dredging. In order to avoid this and because this work has been a
collaborative effort of a rather large group of investigators we
specified which primary analyses we planned to do and how to do
them before we commenced the analysis; this was before the
results of several of the individual studies were known.
The fact that we had access to the raw data from each study gave
us two substantial advantages. First, it allowed us to make the data
from the various centres as compatible as possible, which was
particularly important for the exposure variables. For example, it
made it possible to use the same cut-off points in all studies, to use
geometric means of the measurements, and to focus on exposure
during the year preceding diagnosis. Second, we could arrange
data in ways that were of little interest in themselves for some of
the individual centres because of small numbers, but still of
considerable interest for the total material. In particular this made
it possible to analyse, in a consistent way, higher cut-off points
than the commonly used 0.2 µ T.
For the measurement studies, the findings may have reflected
effects of selection bias due to non-participation. Differences were
observed in several measures of socioeconomic status between
cases and controls, particularly in the US study, with controls
generally characterized by higher socioeconomic status than cases.
In a recent analysis, Hatch et al found that exclusion of partial or
non-cooperative participants from analyses of either in-home
magnetic field measurements or wire-codes tended to increase the
risk estimates for childhood leukaemia in the US study (Hatch et
al, 2000). This was confirmed in the UK study in which there was
a moderate association between a deprivation index and measured
magnetic fields (UKCCS, 1999). This suggests that at least some
of the elevation of risk estimates arose from differential participa-
tion of cases and controls.
Exposure measurements from both calculated and measured
field studies are subject to error. Time-weighted average in a single
24- or 48-hour period immediately prior to diagnosis may not
represent typical levels or the proper metric at the time period that
is relevant for assessing risk of leukaemia, if any, and may not
reflect the exposure of a child living in the home. Calculated fields
are also averages over time and do not take individual characteris-
tics of homes into consideration. Since elevated risk appears to be
confined to only the small fraction of children who are highly
exposed and since we have no basis for determining the pattern of
measurement errors in each study, we cannot reliably infer the
underlying risk function that would be consistent with the
observed risk pattern.
One feature of our results is the high degree of consistency
between the group of studies with measured fields and the group of
studies with calculated fields. This may be of significance when
considering potential confounders because in the calculated fields
studies, the dominant source of exposure is high voltage power
lines, while in the measured fields studies internal sources (such as
ground currents, household wiring, and exposures from electrical
appliances) may predominate. In effect one would not expect the
same confounders to be operating in these two types of studies.
This may also be of significance when considering selection bias
problems, because the calculated fields studies are using popula-
tion registries in a way that makes selection bias a small issue. In
this comparison between the measurement studies and the calcu-
lated fields studies, one must keep in mind, however that the calcu-
lated fields studies are small and based only on a total of 8 cases
with exposure in the highest exposure category.
One of our goals was to see whether controlling for as many
putative confounders as possible would change the results, but
none of the covariates that we had access to changed the results in
any substantial way when included in the models. On the other
hand, none of these is an established risk factor for childhood
leukaemia. Indeed, knowledge about risk factors for childhood
leukaemia is very limited so one cannot exclude the possibility that
adjustment for some other variable would have an effect. For the
moment we can only conclude that mobility, traffic exhaust, type
of dwelling, and urban/rural residency are not important
confounders when studying EMF and childhood leukaemia.
An interesting finding in our analysis relates to the so-called
wire-code paradox. In an earlier review, an expert committee noted
on the basis of the earlier studies that there is a stronger association
between markers for EMF exposure and leukaemia risk than
between direct measurements and leukaemia risk (National
Research Council, 1996). Our data based on subsequent studies do
not support this. In fact, the two North American studies show no
evidence of increased risk associated with residing in homes in
high wire-code categories. It is also worth noting that the measured
magnetic fields are low in all the wire-code categories. The
reasons for the elevated risk estimates for high wire-code cate-
gories in the earlier North American studies are unclear, although
considerable potential for bias has been noted for both studies
carried out in Denver (Portier and Wolfe, 1998).
The results of numerous animal experiments and laboratory
studies examining biological effects of magnetic fields have
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Table 6 Total leukaemia. Relative risks (95% CI) by wire-code with adjustment for age, sex, SES (local definitions) and mobility, number
of subjects, and EMF levels based on subset of subjects with measurement on home used in wire code analysis.
North American studies UG/VLCC1 OLCC2 OHCC3 VHCC4
Canada 1 0.98 (0.66–1.46) 0.75 (0.52–1.10) 1.59 (0.90–2.82)
Case/control 151/154 77/77 83/105 39/23
USA 1 1.03 (0.73–1.44) 1.04 (0.71–1.51) 0.87 (0.47–1.61)
Case/control 177/173 119/115 88/87 24/26
All North American studies 1 1.01 (0.78–1.30) 0.89 (0.68–1.16) 1.24 (0.82–1.87)
EMF level, median in controls 0.04 0.05 0.08 0.11
1Under ground/very low current configuration; 2Ordinary low current configuration; 3Ordinary high current configuration; 4Very high current
configuration. 698 A Ahlbom et al
British Journal of Cancer (2000) 83(5), 692–698 © 2000 Cancer Research Campaign
produced no evidence to support an aetiologic role of magnetic
fields in leukaemogenesis (Portier and Wolfe, 1998). Four lifetime
exposure experiments have produced no evidence that magnetic
fields, even at exposure levels as high as 2000 µ T, are involved in
the development of lymphopoietic malignancies. Several rodent
experiments designed to detect promotional effects of magnetic
fields on the incidence of leukaemia or lymphoma have also been
uniformly negative. There are no reproducible laboratory findings
demonstrating biological effects of magnetic fields below 100 µ T.
Our results have clear implications for future studies. The level
of significance that we see for the excess risk at high exposure
makes chance an unlikely explanation. Future studies will be of
use only if the operation of selection bias and confounding can be
adequately addressed, and if there are sufficient numbers with
exposure over 0.4 µ T.
In summary, for exposure up to 0.4 µ T our data demonstrate
relative risks near the no-effect level. For the very small proportion
(0.8%) of subjects with exposure above 0.4 µ T, the data show a
two-fold increase, which is unlikely to be due to random vari-
ability. The explanation for the elevated risk estimate is unknown,
but selection bias may have accounted for some of the increase.
ACKNOWLEDGEMENTS
We are indebted to the following scientists for input during the
planning: Ben Armstrong, Anssi Auvinen, Ray Cartwright, Gerald
Draper, Elisabeth Hatch, Kauko Heikkilä, Klea Katsouyanni, Ruth
Kleinerman, Markku Koskenvuo, Corrado Magnani, Rolf Meinert,
Sam Pattenden, Eero Pukkala, Alberto Salvan, Joachim Schuez,
Lorenzo Simonato, and Sholom Wacholder. The study was
supported by funding from the Commission of the European
Communities, Contract no. BMH4-CT96-0186 and the Swedish
Medical Research Council.
REFERENCES
Dockerty JD, Elwood JM, Skegg DCG and Herbison GP (1998) Electromagnetic
field exposures and childhood cancers in New Zealand. Cancer Causes and
Control 9: 209–309. Erratum in 1999; 10: 641.
Feychting M and Ahlbom A (1993) Magnetic fields and cancer in children residing
near Swedish high voltage power lines. American Journal of Epidemiology
138: 467–481.
Green LM, Miller AB, Villeneuve PJ, Agnew DA, Greenberg ML, Jiehui L and
Donnelly KE (1999) A case-control study of childhood leukemia in Southern
Ontario, Canada, and exposure to magnetic fields in residences. International
Journal of Cancer 82: 161–170.
Green LM, Miller AB, Agnew DA, Greenberg ML, Jiehui L, Villeneuve PJ and
Tibshirani R (1999) Childhood leukemia and personal monitoring of residential
exposures to electric and magnetic fields in Ontario, Canada. Cancer Causes
and Control 10: 233–243.
Hatch EE, Kleinerman RA, Linet MS, Tarone RE, Kaune WT, Auvinen A, Baris D,
Robison LL and Wacholder S (2000) Residential wiring codes and magnetic
fields: Do confounding or selection factors distort findings of EMF studies?
Epidemiology 11: 189–198.
Linet MS, Hatch EE, Kleinerman RA, Robison LL, Kaune WT, Friedman DR,
Severson RK, Haines CM, Hartsock CT, Niwa S, Wacholder S and Tarone RE
(1997) Residential exposure to magnetic fields and acute lymphoblastic
leukemia in children. New Engl J Med 337: 1–7.
McBride ML, Gallagher RP, Theriault G, Armstrong BG, Tamaro S, Spinelli JJ,
Deadman JE, Fincham S, Robson D and Choi W (1999) Power frequency
electric and magnetic fields and risk of childhood leukemia in Canada.
American Journal of Epidemiology 149: 831–842
Michaelis J, Schuez J, Meinert R, Zemann E, Grigat J-P, Kaatsch P, Kaletsch U,
Miesner A, Brinkman K, Kalkner W and Kärner H (1998) Combined risk
estimates for two German population-based case-control studies on residential
magnetic fields and childhood acute leukemia. Epidemiology 9: 92–94
National Research Council (1996) Possible health effects of exposure to residential
electric and magnetic fields. Washington DC: National Academy Press
Olsen JH, Nielsen A and Schulgen G (1993) Residence near high voltage facilities
and risk of cancer in children. British Medical Journal 307: 891–895
Portier CJ and Wolfe MS (eds) (1998) National Institute of Environmental Health
Sciences Working Goup Report Assessment of health effects from exposure to
power-line frequency electric and magnetic fields. Research Triangle Park:
NIH publication No. 98–3981
Tynes T and Haldorsen T (1997) Electromagnetic fields and cancer in children
residing near Norwegian high-voltage power lines. American Journal of
Epidemiology 145: 219–226
UK Childhood Cancer Study Investigators (1999) Exposure to power frequency
magnetic fields and the risk of childhood cancer: a case/control study. Lancet
354: 1925–1931
Verkasalo PK, Pukkala E, Hongisto MY, Valjus JE, Järvinen PJ Heikkilä PV and
Koskenvuo M (1993) Risk of cancer in Finnish children living close to power
lines. British Medical Journal 307: 895–899
Wertheimer N and Leeper E (1970) Electrical wiring configurations and childhood
cancer. Am J Epidemiol 109: 273–284
Wertheimer N and Leeper E (1982) Adult cancer related to electrical wires near the
home. International Journal of Epidemiology 11: 345–355